Icon

TRIZIVIR (nda021205)- (EQ 300MG BASE;150MG;300MG)

ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE VIIV HLTHCARE
EQ 300MG BASE;150MG;300MG
Yes No
2018-Nov-14 Expired
None None
None No
TRIZIVIR, a combination of abacavir, lamivudine, and zidovudine, each nucleoside analogue HIV-1 reverse transcriptase inhibitors, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
1 1 1
Total Other Developers 1
Drugs with Suitability No
EQ 300MG BASE;150MG;300MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** *** ***** ******* *********** ****-*, **** **. *-* *** *-*-*, ******* ******** **** ***** **, ****. ****, ******* ****, ****. ****, *********, ****** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.